Home › Funds › ICONIQ Capital, LLC › NMRA
ICONIQ Capital, LLC position in NMRA
NEUMORA THERAPEUTICS INC. · Health Care
ICONIQ Capital, LLC reported holding 2,559,090 shares of NMRA (NEUMORA THERAPEUTICS INC.) in its Q2 2026 13F filing — a position valued at US$4.4M, representing 0.13% of its reported portfolio and ranking #37 among its reported holdings. ICONIQ Capital, LLC has disclosed NMRA holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ICONIQ Capital, LLC's NMRA position evolved
ICONIQ Capital, LLC first disclosed a stake in NMRA in Q4 2023 at 3,398,628 shares (US$57.9M). Across 11 filings, ICONIQ Capital, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 9 time(s). The most recent filing (Q2 2026) shows 2,559,090 shares valued at US$4.4M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 3.40M | $57.95M | New |
| Q1 2024 | 3.40M | $46.73M | Hold |
| Q2 2024 | 3.40M | $33.41M | Hold |
| Q3 2024 | 3.40M | $44.90M | Hold |
| Q4 2024 | 2.56M | $27.13M | Reduce |
| Q1 2025 | 2.56M | $2.56M | Hold |
| Q2 2025 | 2.56M | $1.88M | Hold |
| Q3 2025 | 2.56M | $4.66M | Hold |
| Q4 2025 | 2.56M | $4.58M | Hold |
| Q1 2026 | 2.56M | $4.99M | Hold |
| Q2 2026 | 2.56M | $4.35M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NMRA and 13F data
NMRA (NEUMORA THERAPEUTICS INC.) is a Health Care company. 22 other funds we track also report a position in NMRA — the largest reported positions include SOFTBANK GROUP CORP. (US$10.4M), MIC Capital Management UK LLP (US$7.6M), WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST (US$5.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NMRA
- SOFTBANK GROUP CORP. 6.09M sh · $10.35M · Q2 2026
- MIC Capital Management UK LLP 4.46M sh · $7.58M · Q2 2026
- WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST 3.31M sh · $5.63M · Q2 2026
- Lunate Capital Ltd 2.12M sh · $3.61M · Q2 2026
- Boxer Capital Management, LLC 2.00M sh · $3.40M · Q2 2026
- JOHNSON & JOHNSON 1.85M sh · $3.14M · Q2 2026
More on ICONIQ Capital, LLC
FAQ
How long has ICONIQ Capital, LLC held NMRA?
ICONIQ Capital, LLC has disclosed NMRA holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
What is ICONIQ Capital, LLC's current position in NMRA?
As of Q2 2026, ICONIQ Capital, LLC holds 2.56M shares of NMRA (NEUMORA THERAPEUTICS INC.), valued at $4.35M, representing 0.13% of its reported portfolio and ranking #37.
Has ICONIQ Capital, LLC been buying or selling NMRA?
In the latest 13F filing (Q2 2026), ICONIQ Capital, LLC held unchanged its position in NMRA.
Which other funds hold NMRA?
Other major institutional holders of NMRA include SOFTBANK GROUP CORP., MIC Capital Management UK LLP, WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST, among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.